Page last updated: 2024-09-05

sorafenib and ku 55933

sorafenib has been researched along with ku 55933 in 1 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(ku 55933)
Trials
(ku 55933)
Recent Studies (post-2010) (ku 55933)
6,5207305,2511640127

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)ku 55933 (IC50)
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoformHomo sapiens (human)0.458
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoformHomo sapiens (human)0.133
Serine/threonine-protein kinase mTORHomo sapiens (human)7.44
DNA-dependent protein kinase catalytic subunitHomo sapiens (human)1.4943
Serine-protein kinase ATMHomo sapiens (human)0.191

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Knight, ZA; Shokat, KM1

Reviews

1 review(s) available for sorafenib and ku 55933

ArticleYear
Features of selective kinase inhibitors.
    Chemistry & biology, 2005, Volume: 12, Issue:6

    Topics: Animals; Drug Evaluation, Preclinical; Humans; Phosphoric Monoester Hydrolases; Protein Kinase Inhibitors; Substrate Specificity

2005